Neurogene (NGNE) Interest & Investment Income (2013 - 2026)
Neurogene (NGNE) posted Interest & Investment Income of $2.3 million for Q1 2026, down 15.41% on a QoQ basis from $2.7 million in Q4 2025, and down 29.48% year-over-year from $3.2 million in Q1 2025.
Neurogene (NGNE) Interest & Investment Income (2013 - 2026) Analysis & Trends
Neurogene's Interest & Investment Income history runs 12 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Interest & Investment Income fell 29.48% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (up 13.34% YoY) and the FY2025 annual result came in at $11.5 million, up 36.38% from the prior year.
- Interest & Investment Income was $2.3 million for Q1 2026 at Neurogene, down from $2.7 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.2 million in Q1 2025 and bottomed at $650000.0 in Q3 2023.
- A 4-year average of $1.9 million and a median of $2.3 million in 2026 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2024 — Interest & Investment Income jumped 198.58% — and 2026, when it declined 29.48%.
- Neurogene's Interest & Investment Income stood at $781000.0 in 2023, then surged by 190.65% to $2.3 million in 2024, then grew by 17.75% to $2.7 million in 2025, then fell by 15.41% to $2.3 million in 2026.
- Business Quant data shows NGNE's Interest & Investment Income at $2.3 million in Q1 2026, $2.7 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Neurogene | 771.78 Mn | 771.78 Mn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 3.21 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 781,000.00 |
| Sep 30, 2023 | 650,000.00 |
| Jun 30, 2023 | 743,000.00 |
| Mar 31, 2023 | 777,000.00 |
| Mar 31, 2020 | 434,000.00 |
| Mar 31, 2019 | 450,000.00 |
| Sep 30, 2018 | 2,000.00 |
| Jun 30, 2018 | 22,000.00 |
| Mar 31, 2018 | 46,000.00 |
| Dec 31, 2017 | -621,000.00 |
| Sep 30, 2017 | 236,000.00 |